- Report
- December 2021
- 296 Pages
Global
From €2495EUR$2,625USD£2,096GBP
€4991EUR$5,250USD£4,193GBP
- Report
- May 2023
- 240 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- August 2023
- 180 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 175 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 114 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- June 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 126 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- July 2021
- 112 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- May 2023
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2023
- 1300 Pages
Global
From €8461EUR$8,900USD£7,108GBP
The CRISPR Gene Editing market is a subset of the larger Genomics market. It is a rapidly growing field, driven by advances in gene editing technology and the potential for its applications in a variety of areas. CRISPR technology enables scientists to make precise changes to the genetic code of living organisms, allowing them to modify or delete genes, and even insert new ones. This technology has the potential to revolutionize the way we treat diseases, create new crops, and even modify the human genome.
The CRISPR Gene Editing market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and Horizon Discovery. Show Less Read more